Nephrocare Health Services Limited IPO
Nephrocare Health Services Limited IPO
Nephrocare Health Services Limited IPO
₹ 14720 / 32 Shares Shares
Minimum Investment
Nephrocare Health Services Limited IPO
Issues Price
₹438-460 per equity share
Nephrocare Health Services Limited IPO
Open Date
10 Dec 2025
Close Date
12 Dec 2025
Lot Size
16
Min. Investment
₹ 14720
Issue Price
₹438-460
Listing Date
17 Dec 2025
Issues Size
1,89,35,819 shares(aggregating up to ₹871.05 crore)
Face Value
₹2 Per Equity Share
Total Shares Offered
32 Shares
Offered To Public
32 Shares
Nephrocare Health Services Limited IPO
Nephrocare Health Services Ltd, incorporated in the year 2010, is an end-to-end dialysis care provider through its wide network of clinics across India and select international markets. It offers services such as diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy. As of March 31, 2025, Nephrocare operated 490 clinics—447 in India and 43 across the Philippines, Uzbekistan, and Nepal. This includes the world’s largest dialysis clinic in Uzbekistan. In India, the company had a presence across 269 cities in 21 States and four Union Territories. Approximately 76.73% of its clinics were located in tier II and tier III cities, addressing a critical need in underserved regions. In Fiscal 2025, Nephrocare treated 29,281 patients and performed more than 2.88 million dialysis treatments, amounting to approximately 10% of the country's total dialysis patient base. The number of dialysis machines operated by the company increased to 5,068 as of March 2025 from 4,714 in Fiscal 2024 and 3,662 in Fiscal 2023. Nephrocare has formulated strategic alliances with leading hospital chains like Max Super Speciality Hospital, Fortis Escorts Hospitals, Care Hospitals, Wockhardt Hospitals, Paras Healthcare, The Calcutta Medical Research Institute, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers. As of March 2025, the workforce consisted of 3,230 employees, including both medical and administrative staff working across its clinics and corporate office.
Founded In
2010
Managing Director
Vikram Vuppala
Parent Organization
Nephrocare Health Services Limited IPO
Application for Nephrocare Health Services Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Retail (min) | ₹438-460 | ₹14,720 |
| Retail(max) | ₹438-460 | ₹1,91,360 |
| SHNI(min) | ₹438-460 | ₹2,06,080 |
| SHNI(max) | ₹438-460 | ₹9,86,240 |
| BHNI(min) | ₹438-460 | ₹10,00,960 |
Apply for all eligible candidates, Nephrocare Health Services Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
I've explored several NFOs through KSquare, and their consistent communication builds trust. It’s great having expert updates every step of the way.
KSquare made mutual fund investing enjoyable. I track everything on one dashboard and have learned a lot through their educational resources. Perfect for professionals.
KSquare offered everything I needed to invest from the UK. Their NRI Corner is efficient, clear, and built with trust.
I enrolled in NPS through KSquare and found their portal extremely intuitive. Their team guided me at every step.
I’m impressed by how easy KSquare made mutual fund investing. Their platform is clean, quick, and their support staff is always ready to help.
I appreciated how KSquare simplified the NPS jargon. Everything was laid out clearly with ongoing support.
As someone new to investing, KSquare’s SIP guidance has been incredibly helpful. Their platform is user-friendly, and the support team answered all my questions patiently.
I’ve tested many platforms, but KSquare stands out for their transparency and consistent performance. SIPs with them feel like a smart, hassle-free decision.
Living overseas, I struggled with Indian investments. KSquare’s NRI Corner fixed that. Their expert advice and ease of access gave me complete peace of mind.
KSquare gave me confidence to grow wealth in India from abroad. The onboarding was smooth, and they guided me at every step.
FAQ's
Frequenlty Asked Question
Can I use LAMF for personal or business purposes?
Yes, the loan can be used for any legal personal or business need such as emergencies, education, or working capital.
How does KSquare help with mutual fund selection?
KSquare uses algorithms, market insights, and advisor expertise to recommend funds suited to your goals and risk level.
Can I set up automatic investments through KSquare?
Yes, KSquare allows SIP setup, automating monthly investments to help build disciplined saving habits.
What is the typical duration of an NFO subscription period?
NFOs generally remain open for 7 to 15 days, after which the scheme is closed for subscription until listed.
Can I withdraw my mutual fund investment anytime?
Most mutual funds offer liquidity, allowing you to redeem units anytime, except for closed-ended and ELSS funds with lock-ins.
How do I repay the loan taken against mutual funds?
You can repay the loan in EMIs or lump sum, as per the agreed terms. KSquare offers reminders and easy tracking.
How are NFO units allotted after subscription closes?
After the subscription period, units are allotted based on the face value and investment amount on the allotment date.
What types of mutual funds are available on KSquare?
KSquare offers equity, debt, hybrid, ELSS, and index funds to suit different financial goals and risk profiles.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.